No Security Risks Detected
This domain appears to be safe and secure
100%
Score
Disclaimer: This assessment is based on automated analysis of publicly available information. Results are for informational purposes only. For critical applications, consult security professionals.
Scan Information
Last checked:March 19, 2026 12:21:50
Target URL:https://pepvantag.pages.dev/
Scan Complete
Refresh page after 10 minutes
for updated results
Page Information
Target URL
https://pepvantag.pages.dev/
Page Title
PepVantage - 多肽制药行业追踪平台
Status
Active
Host Information
Domain
pepvantag.pages.dev
Server
cloudflare
Country
United States
IP Address
172.66.44.126
ASN Information
13335
CLOUDFLARENET
Technologies
Chart.js
JavaScript graphics
jsDelivr
CDN
HSTS
Security
Cloudflare
CDN
HTTP/3
Miscellaneous
SSL Certificate
HTTPS Enabled
Secure
Certificate Issuer
N/A
Valid From
2026-03-18 12:21:53
Valid Until
2027-03-19 12:21:53
Subject Name
pepvantag.pages.dev
Performance Statistics
3
Total Requests
2
Domains
2
IP Addresses
138.27 KB
Transfer Size
Content Size473.6 KB
HTTP Headers
Access-Control-Allow-Origin
*
CF-RAY
9dec70828ae4f5d9-AMS
Cache-Control
public, max-age=0, must-revalidate
Connection
keep-alive
Content-Encoding
br
Content-Type
text/html; charset=utf-8
Date
Thu, 19 Mar 2026 12:21:53 GMT
ETag
W/"68346acfdd2b989946c45255d7a33193"
Nel
{"report_to":"cf-nel","success_fraction":0.0,"max_age":604800}
Report-To
{"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=NjXAY30uz%2FFbrqj41Wv81PNAAvnZmHhT%2FdpaPhP%2FASq6zvGAvGUHdpZ3NkgaKtgPl9XRZ77yQjV82btiiaD80Ctyr3haOM3zDoTD%2FDIyyRJ%2F"}]}
Server
cloudflare
Transfer-Encoding
chunked
alt-svc
h3=":443"; ma=86400
referrer-policy
strict-origin-when-cross-origin
x-content-type-options
nosniff
15 headers detected
Technology Stack Analysis
Chart.js
JavaScript graphics
Chart.js is an open-source JavaScript library that allows you to draw different types of charts by using the HTML5 canvas element.
jsDelivr
CDN
JSDelivr is a free public CDN for open-source projects. It can serve web files directly from the npm registry and GitHub repositories without any configuration.
HSTS
Security
HTTP Strict Transport Security (HSTS) informs browsers that the site should only be accessed using HTTPS.
Cloudflare
CDN
Cloudflare is a web-infrastructure and website-security company, providing content-delivery-network services, DDoS mitigation, Internet security, and distributed domain-name-server services.
HTTP/3
Miscellaneous
HTTP/3 is the third major version of the Hypertext Transfer Protocol used to exchange information on the World Wide Web.
External Links 27
司美格鲁肽中国核心专利明日（3月20日）到期，国内逾十家仿制药企整装待发 - 摩熵医药
www.pharnexcloud.com
Target URL
https://www.pharnexcloud.com
腰斩、两折！司美格鲁肽、替尔泊肽集体降价，2026年减重药竞争前移 - 财联社
www.cls.cn
Target URL
https://www.cls.cn
礼来口服小分子GLP-1 Orforglipron头对头击败司美格鲁肽 - 医药魔方
bydrug.pharmcube.com
Target URL
https://bydrug.pharmcube.com
GLP-1产能之殇，礼来豪掷200亿打造下一个"超级药王" - 新浪网
news.google.com
Target URL
https://news.google.com/rss/articles/CBMijwFBVV95cUxONjJOS2NaVkc5ZzVwOWtjV0dzUmpQSTQycnVwRElZbkRPQTlFMmFqWnlKVFhfa0otdGZrX25LMDN1Y1Nab2U1QllIYk1xUGM3RUowdnA5OXgwa3ZiVm5LblZwbFR3aGxEYWRCSkdYWFlldW9kWDc1NmtJME5XcEJUS2ZEZjBPLV9Yd1djSEZwdw?oc=5
翰森奥莱泊肽III期成功：体重下降19.3%，国产GLP-1/GIP双靶点提速入场 - OFweek
www.ofweek.com
Target URL
https://www.ofweek.com/medical
减肥药进入"口服时代"！药企积极抢滩产业链机遇 - 证券时报
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiXEFVX3lxTE5oZnZNMFkxa1d0d29HdVE2UW5aTHFNRGtfMWsyenczSVRPaXk0MDNUWk9TOU45R2htcFRVYjNXNG80d0NVbkZ3M0VlZEpSZXhyNm5kbmVsWUtYUjhq?oc=5
Semaglutide patent in China expires tomorrow (March 20) — over 10 generics makers ready to launch - Reuters
www.reuters.com
Target URL
https://www.reuters.com/business/healthcare-pharmaceuticals/
Stopping GLP-1 drugs can quickly erase cardiovascular benefits - WashU Medicine
medicalxpress.com
Target URL
https://medicalxpress.com/news/2026-03-glp-drugs-quickly-erase-cardiovascular.html
Tirzepatide outperforms semaglutide for weight loss in large real-world study - JAMA Internal Medicine
news.gastro.org
Target URL
https://news.gastro.org
In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12 - Fierce Pharma
news.google.com
Target URL
https://news.google.com/rss/articles/CBMivgFBVV95cUxOSFhDZG9vY01ONzRSOFhKeDkxUGFPN254WmZQcHhIYnExUm9wR3lHSzNuOU9VRmdyZncwX2ZTS1M3ZE1XRzRMVEVFTEpLV3dGX1FmZHJvR1J4WmNOR2loRjFvVmhrdWNLeXIzQnpNZzkwSDFoQVFCUTVMVkFaMy1NcXVXZmFDVFZ0UUF3bXU3MjdHZ0VlaHVUQWhxd19jelVEOTF5UkktaHdRbDh3QmlHU1FaSzcwQ05XcWZ2QTlR?oc=5
Novo, Hims reach deal to sell GLP-1 drugs together - BioPharma Dive
news.google.com
Target URL
https://news.google.com/rss/articles/CBMijwFBVV95cUxNR0ExOWViTmkxMW4wbXQ0RGpoWEtCeDhBZ1VuZUYyNGhrdlNKSkJQYW5UeWRYOW4wZ3ZKZ0dmOHAwUW5BUVpKb3EwWFM0cWpJQk9nY29ySUVxMG5GYWJWUjY0UjhRclctVk4yYlE0eTB5QnVKVWxVTUhORlJTTnVuT2FhNEJtSjlMcnMwU2x2aw?oc=5
Lilly's GLP-1 pill tops Novo's Rybelsus in head-to-head trial - BioPharma Dive
news.google.com
Target URL
https://news.google.com/rss/articles/CBMioAFBVV95cUxPVGhraW5YYm9BRlJFTjlyVWlBUk9CdzV1T2FjVFFfOTJMa25VNTdVb3h1b3E3cWtLVkROTG5iVUdBZURpQ1NjN1dCOGVCMVlhaVBRT1NtcEh3WnZqbWRvYTZNdE4yZkw1TVpjelFUQ2l2LXo4c2E1Z0I0NDVIZlA3MFVPaWZjNXY1ZGlpTzB0aHFzZnJvN1VJdDc0eHROSzFH?oc=5
Typ-2-Diabetes: Erster oraler GLP-1-Agonist vor der Zulassung - Deutsches Ärzteblatt
www.aerzteblatt.de
Target URL
https://www.aerzteblatt.de
Neue Hoffnung im Abnehm-Kampf: Roche punktet mit Petrelintide - Pharma+Food
news.google.com
Target URL
https://news.google.com/rss/articles/CBMipgFBVV95cUxPQlpSeWJkYUVVbk1ldzFmQlRrM2l5aW5UMjRiZmVielJjRGtTeDhVQS1Zb1cyUmV4bVVXaFBaNWNpbUNmUDZvTGh5Y2hzU000eDRNU3R2VjBTWjZrR292aWNjMGRjRHN1ZXRMci1JZlBGWTRqbGQ3bmFBNS13bjRMd2JKR01aZXJxZWwwYmlLNzF5aV9DelczTzN5RmNoMFdkZmE3cE5B?oc=5
Im Schatten von Novo Nordisk: Konkurrenz tritt aufs Gaspedal - Der Aktionär
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZjdTbGpoclIzZFVISnBmZkJXOWRqbW5Ua1lqRndLY2pKYmk2U1Z1bnhqLWsyN2hQR1ZFNXY0OHp3NThlQnJfUmM3dWQzRVRwZGNlSjVENFZFYVk2N3NhUG9OVHhDRjZLUVBkNEctVTZvQm1aa2lCQVE3Zy1aMTQySF9NWTUtbllwWDZweHdLTXJ5aXFkVGRhLWVYdmNfd2Uzb0NtWEdybzhabnpSNU9Hc2JZRXIyNGExZGxNQS1KbjdvQQ?oc=5
Metaanalyse: Jo-Jo-Effekt nach Absetzen von GLP-1-Rezeptoragonisten stärker als gedacht - Ärzte Zeitung
news.google.com
Target URL
https://news.google.com/rss/articles/CBMi0gFBVV95cUxOd1E0VTJBdnZsWkpLakowbkZOanBxUGRndEotOVU0YnIxSkVjV1R1RUZ6NUQxWVV6Zm41bWtaQmFDWVQwVVF6QnB6RXZoTThadHpUQThYdll5bGZzVDV4UEhJTVpQOU1GVDlLeFo1a09jX0ZiQjhFSVk0Yi1CaW1aLVktN09LejI2dmt1V25odXhFR09ndHdocDc3T2t4YUZuR0RwZmVTeDhXamRvUkt0UDJoN1dPczhGOFFoQjNoQ0ZJdThWM1dHc2xHdlFyc2JvdGc?oc=5
JPM大会上的中国力量：从沉默围观者到核心参与者，中国创新药企站上全球舞台 - 东方财富
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiYEFVX3lxTE14NzdZMjRqSnZhYW5CVkZabmVLY0x6OGhPMUNyNnptSzRiOERqaGp0cUZUWGhfTTdtWXBZb0JPeGNacE9YVUlmUTdROVpQOHZ6V0NtVTRKbHFDQlhQRTRTWg?oc=5
JPM大会首设Beyond K-Beauty专场，医美科技和皮肤长寿成为全球医疗投资新焦点 - 新浪财经
news.google.com
Target URL
https://news.google.com/rss/articles/CBMihwFBVV95cUxOSDVFa1Nram5qLS1SNTFCZmtJOUxFdi1jWDFibjgtU2lZNkFBV01oWG9PODd0Y1F6UEtXaTNnbjNEbWlSUnB2ZUlLNzRlTkJBN1NUYnZGXzNFS29fOXF5em11NHhnVEpwNjhOdF92czUtM3h3U1dHdVRTUGZnY2NkV3VTSFlWRVk?oc=5
JPM2026大会背后，这些蓝海赛道正悄悄崛起 - 新浪网
news.google.com
Target URL
https://news.google.com/rss/articles/CBMilwJBVV95cUxOMmQ4VmJKRW5CZUxwMGYyWWhORm1tNXY5aWF0WjVxaWlvRFVqUnk2cW1KNERidk9SdVQyZElFQ3kxYmdXbUJoX3IycVl5V1d0WldpeFI1aWJjSjhRY1FtemhHNkFadEVkZUo2YzFuUTV3QVItNnVRV0R0djhGVEt3VmYwN252LTZuc2kwbG1FWVRJRnFMaFZ5QUFTTHFZMW1td3Q5WjF1YXRNV0NGVERGNXhOM2ZnNjAxQlRVa0N4S2xyOXlPRE15dU8td3E4MzJkWWNMLVZDY25kYzVFanhaSWVkUzlsa0hYMWFTNnM1b1AxdW4xb3Uxckk2TGdTYVA3R3VUUUJSeHphTTVGU05KNGg0eFRNaHc?oc=5
出发前就约了四五十家公司洽谈！“全球医药行业春晚”的中国面孔：参会者背景更多元，肿瘤药不再是“独宠” - 每日经济新闻
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiZkFVX3lxTE5UM0hpSTBPVTFLVmwyNHpRV2Nkek4zRXN0X19IN1NRdE1NN0txUTluT2ZjTVRnVGJjVjFrLUVjU1AzVThrZEFUM0x6OGtDM1FaVHVDVXQ5ZlhIMDJWTTV6NjZnM245dw?oc=5
Samsung Biologics weighs acquisition of weight-loss drug plant in US - The Korea Economic Daily Global Edition
news.google.com
Target URL
https://news.google.com/rss/articles/CBMibkFVX3lxTE9jNVR4c3pDbnFGSWwtcV9YUVVUQWV6aVVwd0hfU1VTb3dxY29PX1pQYkJVWGZ4cVR1VDIzbXFOdmJhY1NXbUwyWld3VVdOMHp3bXVwNlJ5LWRXdWxhTFZKUklVdmJYbmlGTm8tN2ln?oc=5
‘Chinese Peptides’ Are the Latest Biohacking Trend in the Tech World - The New York Times
news.google.com
Target URL
https://news.google.com/rss/articles/CBMihwFBVV95cUxPbUJiREZLLW9zNTNOQ29XekRJdWZBME03LTJLTnhfbWl6UDlObUt5aFE1VTNoZlMxbnFvdG1nbG82bVFIeGYyQldIUHdYNTduTWFLN2pBN0hLSkZCSEVhN19ISWpFQ1dnVEJJQTIwWkgtTEVTM0Z1QldPZndmSXN3akhaMFBQT1k?oc=5
Consensus Report: Management of Type 1 Diabetes in Adults - Medscape
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiogFBVV95cUxPOVA3anlZNmZuQkJiZGJHSncycUF5YTlSbExXWHZiZUFveXVrYXd2R2xMOUV1RXhUaDRaVUNxc1VJRGZaNHpmZ212X3liMDN1eUFBeUJKdldTbWF6LVRTeG5xX3lPdk42OHRjM3c1bUlaTlp6TUoxOFQxYkdKVXdxempfbXd2a0otUlBWX042Ri00dVc5Z1pyOVd0ZncteUZSdkE?oc=5
Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing - PR Newswire
news.google.com
Target URL
https://news.google.com/rss/articles/CBMijwJBVV95cUxPdkxORDduQTNrcGhaZkhsTTBrYlEyb1ZLekM4QjBUajVTWm5FUXdEa3pRMTBGcFgybnlZRUNqMDJmTWZOanZnc1JidGU0RmRuQk90cDY3TFA0U3ptVWloVnduYi05ZmNvblRqYnF1NUlOTldQWUJpUFNaVTVFUEM0ZTBKcDhQVjNJYjRwU28yVkNWNy1TWVlnLTB4QXh6ZUpEWnNrOUROblZrZV9NX01rV3Y2YnQ3R0ZTNDJnSnBJMDZSeGl4ZU1kY3FXbU1oOUxaSWZuZlR0Q0VaSW95UGtINFJGZl9oTTRrUk1mZEQ3YTEzSTBMdHFNbmgzUVV2MW1ySGxGMDJZQjV1Vmp0Ym93?oc=5
Neue Evidenz zu Semaglutid - Medical Tribune
news.google.com
Target URL
https://news.google.com/rss/articles/CBMihgFBVV95cUxPU2x1UEVOODdqbkt3bnA0Q29qQ00wTE9DQl9aa09VaGgtdENBVmh0elVFd29pSkkyT1ZHUll1bEdwWGlnMG5URnNCQ0lDR000QzdRT01kWUZ0NC1FeGpCOHZkamEzb2kwZ3U5ckpheVdISkd5OFNFODNPZlQ3dGt4NnZ4QnhYUQ?oc=5
ESC-Leitlinie zu Herzschutz bei Diabetes: SGLT2-Hemmer und GLP-1-Agonisten - Medscape
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiYEFVX3lxTE82aDJRVEd0TVQyUFpRQk9Pc0xOWG41dXZFZzVqWVBVQW1POGh6RHR5N3pWaHpwNmRGRXFpTVlydmlqSVBfVHJrTFhHcTRrWUtJMGtocmZMN2dYUVpzbHlKaQ?oc=5
Sitagliptin: Bietet fürs Herz kaum mehr als andere DPP-4-Hemmer - Medscape
news.google.com
Target URL
https://news.google.com/rss/articles/CBMiYEFVX3lxTE10UEI5MmotVXRwcUFOVlBGX21udmRzY2ZuenVmWG5IVE1CbjZxRHRYeG1IR1ZENUZqNVJwUExDS0dmOHNHT05JT2U4ak1OcHFnUEFMTFN2OFROWldfSVFDSg?oc=5
Requested Domains 2
cdn.jsdelivr.net
Unknown Type
No category information available
pepvantag.pages.dev
Apex domain
No category information available